VERTEX PHARMACEUTICALS INC / MA
Industry: Life Sciences ・ $VRTX on Nasdaq
Insider Sale
+$7,677,010
-14.32%
Shares
Shares Volume: 15,202 Shares
Average Share Price: $505
INSIDER
Kewalramani Reshma
CEO & President (Director)
reported on Aug 1 2024
traded on Jul 30 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 90,970 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $4,477,838.17 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 0 / 51 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,957,597.24 |
| COMPANY PREVIOUS TRADES |